InsiderTrades

Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2021-08-13 00:00:00 ET · period of report 2021-07-08 · accession 0001209191-21-051438 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2021-08-13 2021-07-08+ CPIX Jones James Dir P - Purchase $3.32 +714 15.4K +5% +$2,368

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-07-27 P A 42 $3.39 15,288 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
2 Common Common Stock 2021-07-28 P A 42 $3.42 15,330 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
3 Common Common Stock 2021-07-29 P A 42 $3.42 15,372 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
4 Common Common Stock 2021-07-08 P A 42 $3.18 14,742 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
5 Common Common Stock 2021-07-09 P A 42 $3.13 14,784 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
6 Common Common Stock 2021-07-12 P A 42 $3.33 14,826 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
7 Common Common Stock 2021-07-13 P A 42 $3.48 14,868 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
8 Common Common Stock 2021-07-14 P A 42 $3.33 14,910 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
9 Common Common Stock 2021-07-15 P A 42 $3.27 14,952 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
10 Common Common Stock 2021-07-16 P A 42 $3.28 14,994 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
11 Common Common Stock 2021-07-19 P A 42 $3.23 15,036 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
12 Common Common Stock 2021-07-20 P A 42 $3.24 15,078 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
13 Common Common Stock 2021-07-21 P A 42 $3.26 15,120 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
14 Common Common Stock 2021-07-22 P A 42 $3.36 15,162 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
15 Common Common Stock 2021-07-23 P A 42 $3.35 15,204 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
16 Common Common Stock 2021-07-26 P A 42 $3.39 15,246 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
17 Common Common Stock 2021-07-30 P A 42 $3.31 15,414 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.